{"count": 4, "results": [{"_id": "17996", "pmid": 17996, "title": "Atenolol in the treatment of angina pectoris.", "journal": "Acta Med Scand", "authors": ["Erikssen J", "Osvik K", "Dedichen J"], "date": "1977-01-01T00:00:00Z", "doi": "10.1111/j.0954-6820.1977.tb15751.x", "meta_date_publication": "1977", "meta_volume": "201", "meta_issue": "6", "meta_pages": "579-84", "score": 50075.89, "text_hl": "Fifteen patients had subjective improvement on @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, two were unchanged and two felt worse (because of @<m>DISEASE_Asthenia</m> @DISEASE_MESH:D001247 @@@asthenia@@@/leg @DISEASE_Fatigue @DISEASE_MESH:D005221 @@@fatigue@@@). ", "citations": {"NLM": "Erikssen J, Osvik K, Dedichen J. Atenolol in the treatment of angina pectoris. Acta Med Scand. 1977;201(6):579-84. PMID: 17996", "BibTeX": "@article{17996, title={Atenolol in the treatment of angina pectoris.}, author={Erikssen J and Osvik K and Dedichen J}, journal={Acta Med Scand}, volume={201}, number={6}, pages={579-84}}"}}, {"_id": "9819786", "pmid": 9819786, "title": "Comparison between moexipril and atenolol in obese postmenopausal women with hypertension.", "journal": "Maturitas", "authors": ["Stimpel M", "Koch B", "Weber MA"], "date": "1998-09-20T00:00:00Z", "doi": "10.1016/s0378-5122(98)00037-1", "meta_date_publication": "1998 Sep 20", "meta_volume": "30", "meta_issue": "1", "meta_pages": "69-77", "score": 50057.28, "text_hl": "Most frequent adverse events under monotherapy (@CHEMICAL_moexipril @CHEMICAL_MESH:C058302 @@@moexipril@@@/@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@) were @<m>DISEASE_Asthenia</m> @DISEASE_MESH:D001247 @@@asthenia@@@ (5.3/13.0%), @DISEASE_Headache @DISEASE_MESH:D006261 @@@headache@@@ (13.2/21.7%), @DISEASE_Cough @DISEASE_MESH:D003371 @@@cough@@@ (7.9/6.5%), @DISEASE_Pharyngitis @DISEASE_MESH:D010612 @@@pharyngitis@@@ (21.1/8.7%) and @DISEASE_Peripheral_Nervous_System_Diseases @DISEASE_MESH:D010523 @@@peripheral oedema@@@ (5.3/13.0%). ", "citations": {"NLM": "Stimpel M, Koch B, Weber MA. Comparison between moexipril and atenolol in obese postmenopausal women with hypertension. Maturitas. 1998 Sep 20;30(1):69-77. PMID: 9819786", "BibTeX": "@article{9819786, title={Comparison between moexipril and atenolol in obese postmenopausal women with hypertension.}, author={Stimpel M and Koch B and Weber MA}, journal={Maturitas}, volume={30}, number={1}, pages={69-77}}"}}, {"_id": "2859865", "pmid": 2859865, "title": "Cadralazine, a new vasodilator, in addition to a beta-blocker for long-term treatment of hypertension.", "journal": "Arzneimittelforschung", "authors": ["Salvadeo A", "Villa G", "Segagni S", "Piazza V", "Picardi L", "Romano M", "Parini J"], "date": "1985-01-01T00:00:00Z", "meta_date_publication": "1985", "meta_volume": "35", "meta_issue": "3", "meta_pages": "623-5", "score": 50053.586, "text_hl": "During @CHEMICAL_cadralazine @CHEMICAL_MESH:C031877 @@@cadralazine@@@ treatment, heart rate was always significantly lower than before @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ alone; the most common side effects, many of which were already present during treatment with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ alone, included @DISEASE_Headache @DISEASE_MESH:D006261 @@@headache@@@, @<m>DISEASE_Asthenia</m> @DISEASE_MESH:D001247 @@@asthenia@@@, @DISEASE_Dizziness @DISEASE_MESH:D004244 @@@dizziness@@@, @DISEASE_Heart_Diseases @DISEASE_MESH:D006331 @@@palpitation@@@ and @DISEASE_Flushing @DISEASE_MESH:D005483 @@@flushing@@@, and tended to disappear spontaneously as therapy progressed. ", "citations": {"NLM": "Salvadeo A, Villa G, Segagni S, Piazza V, Picardi L, Romano M, Parini J. Cadralazine, a new vasodilator, in addition to a beta-blocker for long-term treatment of hypertension. Arzneimittelforschung. 1985;35(3):623-5. PMID: 2859865", "BibTeX": "@article{2859865, title={Cadralazine, a new vasodilator, in addition to a beta-blocker for long-term treatment of hypertension.}, author={Salvadeo A and Villa G and Segagni S and Piazza V and Picardi L and Romano M and Parini J}, journal={Arzneimittelforschung}, volume={35}, number={3}, pages={623-5}}"}}, {"_id": "19610566", "pmid": 19610566, "title": "Ventricular fibrillation as the first manifestation of primary hyperaldosteronism.", "journal": "Bol Asoc Med P R", "authors": ["Delgado Y", "Quesada E", "Pérez Arzola M", "Bredy R"], "date": "2006-10-01T00:00:00Z", "meta_date_publication": "2006 Oct-Dec", "meta_volume": "98", "meta_issue": "4", "meta_pages": "258-62", "score": 50036.305, "text_hl": "50 years old female @SPECIES_9606 @@@patient@@@, with history of @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes mellitus@@@ and @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@, receiving @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ (500 mg BID) and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ (50 mg BID), presented to the Emergency Room with @<m>DISEASE_Asthenia</m> @DISEASE_MESH:D001247 @@@asthenia@@@ and @DISEASE_Dizziness @DISEASE_MESH:D004244 @@@dizziness@@@. ", "citations": {"NLM": "Delgado Y, Quesada E, Pérez Arzola M, Bredy R. Ventricular fibrillation as the first manifestation of primary hyperaldosteronism. Bol Asoc Med P R. 2006 Oct-Dec;98(4):258-62. PMID: 19610566", "BibTeX": "@article{19610566, title={Ventricular fibrillation as the first manifestation of primary hyperaldosteronism.}, author={Delgado Y and Quesada E and Pérez Arzola M and Bredy R}, journal={Bol Asoc Med P R}, volume={98}, number={4}, pages={258-62}}"}}]}